Fake news alert: South Africa will not return 1 million AstraZeneca COVID-19 vaccines received from Serum Institute of India

South Africa had paused the rollout of AstraZeneca coronavirus vaccine doses this month after preliminary trial data showed they offered minimal protection against mild to moderate illness from the country's dominant COVID-19 variant. The country is now likely to administer Johnson & Johnson COVID-19 vaccines from Wednesday.